Related references
Note: Only part of the references are listed.Fibroblast Growth Factor 21-Metabolic Role in Mice and Men
Harald Staiger et al.
ENDOCRINE REVIEWS (2017)
FGF-FGFR Mediates the Activity-Dependent Dendritogenesis of Layer IV Neurons during Barrel Formation
Jui-Yen Huang et al.
JOURNAL OF NEUROSCIENCE (2017)
Pharmacokinetics and Pharmacodynamics of a Human Monoclonal Anti-FGF23 Antibody (KRN23) in the First Multiple Ascending-Dose Trial Treating Adults With X-Linked Hypophosphatemia
Xiaoping Zhang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer
Mai Tomiguchi et al.
CANCER SCIENCE (2016)
FGF21 Lowers Plasma Triglycerides by Accelerating Lipoprotein Catabolism in White and Brown Adipose Tissues
Christian Schlein et al.
CELL METABOLISM (2016)
Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice
Jingjing Zhang et al.
CLINICAL SCIENCE (2016)
FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival
Soomin Ahn et al.
MODERN PATHOLOGY (2016)
Amplification of FGFR1 gene and expression of FGFR1 protein is found in different histological types of lung carcinoma
Vitor Sousa et al.
VIRCHOWS ARCHIV (2016)
Effectiveness of basic fibroblast growth factor for pediatric hand burns
Kenji Hayashida et al.
JOURNAL OF TISSUE VIABILITY (2016)
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy
Roberto Ronca et al.
CANCER CELL (2015)
Pharmacologic Effects of FGF21 Are Independent of the Browning'' of White Adipose Tissue
Murielle M. Veniant et al.
CELL METABOLISM (2015)
Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
Zhuofeng Lin et al.
CIRCULATION (2015)
Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries
Paul C. Billings et al.
CONNECTIVE TISSUE RESEARCH (2015)
Targeting fibroblast growth factor receptor pathway in breast cancer
Carmen Criscitiello et al.
CURRENT OPINION IN ONCOLOGY (2015)
Metabolic roles of endocrine fibroblast growth factors
Isabel Fernandes-Freitas et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
FGF-Regulated ETV Transcription Factors Control FGF-SHH Feedback Loop in Lung Branching
John C. Herriges et al.
DEVELOPMENTAL CELL (2015)
Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study
Kwok-Leung Ong et al.
DIABETOLOGIA (2015)
Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinoma
Francesco Massari et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Unliganded Fibroblast Growth Factor Receptor 1 Forms Density-independent Dimers
Laetitia Comps-Agrar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival
Steven E. Thiessen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Pharmacokinetic and pharmacodynamic interactions between palifermin and heparin
Bing-Bing Yang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Complexity of FGFR signalling in metastatic urothelial cancer
Alejo Rodriguez-Vida et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Fibroblast growth factor-21, energy balance and obesity
Marta Giralt et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases
Fangfang Zhang et al.
MOLECULAR ENDOCRINOLOGY (2015)
Glucocorticoids Regulate the Metabolic Hormone FGF21 in a Feed-Forward Loop
Rucha Patel et al.
MOLECULAR ENDOCRINOLOGY (2015)
Phosphate and FGF-23 homeostasis after kidney transplantation
Leandro C. Baia et al.
NATURE REVIEWS NEPHROLOGY (2015)
Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors
Cinta Hierro et al.
SEMINARS IN ONCOLOGY (2015)
Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21
Bryn M. Owen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Accelerated healing in NONcNZO10/LtJ type 2 diabetic mice by FGF-1
Sachiko I. Blaber et al.
WOUND REPAIR AND REGENERATION (2015)
Sodium hyaluronate eye drops treatment for superficial corneal abrasion caused by mechanical damage: a randomized clinical trial in the People's Republic of China
Tong Lin et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Endothelial Rictor is crucial for midgestational development and sustained and extensive FGF2-induced neovascularization in the adult
Fabio Aimi et al.
SCIENTIFIC REPORTS (2015)
High Expression of FGFR4 Enhances Tumor Growth and Metastasis in Nasopharyngeal Carcinoma
Si Shi et al.
JOURNAL OF CANCER (2015)
FGF21, energy expenditure and weight loss - How much brown fat do you need?
Leon Straub et al.
MOLECULAR METABOLISM (2015)
FGFR1 mediates recombinant thrombomodulin domain-induced angiogenesis
Cheng-Hsiang Kuo et al.
CARDIOVASCULAR RESEARCH (2015)
Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease
Luca Di Lullo et al.
CLINICAL KIDNEY JOURNAL (2015)
Low Prognostic Implication of Fibroblast Growth Factor Family Activation in Triple-negative Breast Cancer Subsets
Hee Jin Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Physiological Functions and Underlying Mechanisms of Fibroblast Growth Factor (FGF) Family Members: Recent Findings and Implications for Their Pharmacological Application
Toru Imamura
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2014)
Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitors
Hideki Yamaguchi et al.
CANCER SCIENCE (2014)
Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population The Multi-Ethnic Study of Atherosclerosis
Bryan Kestenbaum et al.
CIRCULATION-HEART FAILURE (2014)
Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia
Thomas O. Carpenter et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Advances in skin grafting and treatment of cutaneous wounds
Bryan K. Sun et al.
SCIENCE (2014)
Clinical application of growth factors and cytokines in wound healing
Stephan Barrientos et al.
WOUND REPAIR AND REGENERATION (2014)
Inventing new medicines: The FGF21 story
Alexei Kharitonenkov et al.
MOLECULAR METABOLISM (2014)
FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases
Nobuyuki Itoh
FRONTIERS IN ENDOCRINOLOGY (2014)
Fibroblast growth factor (FGF) signaling in development and skeletal diseases
Chad M. Teven et al.
GENES & DISEASES (2014)
Approaches targeting the FGF-FGFR system: a review of the recent patent literature and associated advanced therapeutic agents
Corentin Herbert et al.
PHARMACEUTICAL PATENT ANALYST (2014)
The Roles of Fibroblast Growth Factor (FGF)-23, alpha-Klotho and Furin Protease in Calcium and Phosphate Homeostasis : A Mini-Review
Roshan L. Mattoo
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2014)
Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers
Kai Hung Tiong et al.
APOPTOSIS (2013)
Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants
J. D. Goldberg et al.
BONE MARROW TRANSPLANTATION (2013)
Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
Zhuofeng Lin et al.
CELL METABOLISM (2013)
The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
Gregory Gaich et al.
CELL METABOLISM (2013)
FGFR2 Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547
Liang Xie et al.
CLINICAL CANCER RESEARCH (2013)
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications
Saroj Vadhan-Raj et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
FGFR3 Mutation Analysis in Voided Urine Samples to Decrease Cystoscopies and Cost in Nonmuscle Invasive Bladder Cancer Surveillance: A Comparison of 3 Strategies
Kim E. M. van Kessel et al.
JOURNAL OF UROLOGY (2013)
Blockade of Nonhormonal Fibroblast Growth Factors by FP-1039 Inhibits Growth of Multiple Types of Cancer
Thomas C. Harding et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Molecular Mechanisms of Fibroblast Growth Factor Signaling in Physiology and Pathology
Artur A. Belov et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
FGFR2 gene amplification and clinicopathological features in gastric cancer
K. Matsumoto et al.
BRITISH JOURNAL OF CANCER (2012)
FGF/FGFR signaling in bone formation: Progress and perspectives
Pierre J. Marie et al.
GROWTH FACTORS (2012)
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
Victoria Shalhoub et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens et al.
NATURE (2012)
High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated
Camilla Krakstad et al.
PLOS ONE (2012)
The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies
A. Kalff et al.
BLOOD CANCER JOURNAL (2012)
Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells
Marianne E. Marshall et al.
CLINICAL CANCER RESEARCH (2011)
Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition
Elizabeth Allen et al.
CLINICAL CANCER RESEARCH (2011)
Acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial
Jau-Ching Wu et al.
JOURNAL OF NEUROSURGERY-SPINE (2011)
Optimization of Nonmuscle Invasive Bladder Cancer Recurrence Detection Using a Urine Based FGFR3 Mutation Assay
Tahlita C. M. Zuiverloon et al.
JOURNAL OF UROLOGY (2011)
Chromosome 8p11.2 translocations: Prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile
Zhuofeng Lin et al.
PLOS ONE (2010)
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
Michael G. Gartside et al.
MOLECULAR CANCER RESEARCH (2009)
Actions and mode of actions of FGF19 subfamily members
Seiji Fukumoto
ENDOCRINE JOURNAL (2008)
A neutralizing anti-fibroblast growth factor (FGF)8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions
Kurniko Maruyama-Takahashi et al.
PROSTATE (2008)
Functional evolutionary history of the mouse Fgf gene family
Nobuyuki Itoh et al.
DEVELOPMENTAL DYNAMICS (2008)
Randomized, multicenter, double-blind, and placebo-controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial-thickness burns and skin graft donor site
Ma Bing et al.
WOUND REPAIR AND REGENERATION (2007)
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes
P. M. Pollock et al.
ONCOGENE (2007)
A neutralizing anti-fibroblast growth factor 8 monoclonal antibody shows potent antitumor activity against androgen-dependent mouse mammary tumors in vivo
N Shimada et al.
CLINICAL CANCER RESEARCH (2005)
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity
SK Olsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation
CO Freytes et al.
CLINICAL CANCER RESEARCH (2004)
Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs
SK Olsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Randomized trial of topically applied, repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers
MC Robson et al.
WOUND REPAIR AND REGENERATION (2001)
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
J Khan et al.
NATURE MEDICINE (2001)
Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity
AN Plotnikov et al.
CELL (2000)
Share Paper
